Skip to main content
Beyfortus Coupon - Beyfortus five 0.5ml prefilled syringes of 50mg/0.5ml carton

Beyfortus

nirsevimab
Used for RSV

Beyfortus (nirsevimab or nirsevimab-alip) is an injection given to babies and children up to 24 months old. It's used to prevent them from getting very sick from respiratory syncytial virus (RSV). It's not an RSV vaccine. Instead, it's a monoclonal antibody that gives protection against the virus for a short time. Beyfortus (nirsevimab) is now part of the CDC Child Immunization Schedule. The usual dosage is 1 to 2 injections into the muscle during or at the start of the RSV season. It's well-tolerated with only a few side effects.

Reviewed by:Last reviewed on August 11, 2025
basics-icon

What is Beyfortus (nirsevimab)?

What is Beyfortus (nirsevimab) used for?

  • Prevention of respiratory syncytial virus (RSV) in young children of certain ages
    • Newborns and infants born during or entering their first RSV season
    • Children up to 24 months old at risk of severe RSV illness through their second RSV season

How Beyfortus (nirsevimab) works

Beyfortus (nirsevimab) is a type of monoclonal antibody. It attaches to a specific protein found on RSV (called the prefusion F protein).

By attaching to this protein, it prevents RSV from getting into cells and spreading in the body. This helps protect against RSV and lower the risk of serious illness if you do get sick from it.

When does Beyfortus (nirsevimab) start working?Time passed since treatment started:
HOURS
Full effect
DAYS
WEEKS
MONTHS

Drug facts

Common BrandsBeyfortus
Drug ClassMonoclonal antibody
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
side-effects-icon

Side effects of Beyfortus (nirsevimab)

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Side effects aren't common. See Other Side Effects.

Less Common Side Effects

  • Rash
  • Injection site reaction (e.g., pain, hard lump, swelling)

Beyfortus (nirsevimab) serious side effects

Contact your healthcare provider immediately if you experience any of the following.

  • Severe allergic reaction: rash, trouble breathing, swelling in the face or throat
When do Beyfortus (nirsevimab) possible side effects begin and end?
Time passed since treatment started:
H
D
W
M
Rash
Injection site reaction

Source: DailyMed

The following Beyfortus (nirsevimab) side effects have also been reported

Side effects that you should report to your care team as soon as possible:

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Pain, redness, or irritation at injection site
  • Skin rash
pros-and-cons-icon

Pros and cons of Beyfortus (nirsevimab)

Pros

  • Given during one medical visit
  • Can lower the risk of severe RSV-related illness by about 70% in full-term and premature babies
  • Not many side effects

Cons

  • Injection can be uncomfortable
  • Protection might only last for about 5 months
  • Not known if it's safe or if it works well for children older than 24 months
pharmacist-tips-icon

Pharmacist tips for Beyfortus (nirsevimab)

pharmacist
  • Your child should get Beyfortus (nirsevimab) at the start of or during the RSV season. It's usually between late fall and early spring. Ask your child's pediatrician about when RSV season begins in your area. This can help you plan out when your child should get the injection.
  • Your child could get a rash after getting Beyfortus (nirsevimab). There could also be pain and swelling where the injection was given. These side effects usually happen within 1 to 2 weeks of the injection. But they should go away in a few days. Talk to a healthcare professional about ways to help relieve these side effects.
  • If your child got Beyfortus (nirsevimab) for their first RSV season, ask the pediatrician if they should get it again for the next season. This usually depends on if your child is still at high risk of getting very sick from RSV.
  • Even though Beyfortus (nirsevimab) can lower your child's risk of RSV, they could still get infected and get sick. Watch out for symptoms of RSV. They include a stuffy or runny nose, cough, sore throat, and a low-grade fever.
  • If your child has heart surgery, talk to the pediatrician. Your child might need an extra dose of Beyfortus (nirsevimab) afterwards. Heart surgery might affect the levels of the antibody medication in the body. So an extra dose helps make sure your child is still protected enough from RSV.
educational-icon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more
warnings-icon

Risks and warnings for Beyfortus (nirsevimab)

Beyfortus (nirsevimab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

Severe allergic reaction

Some children have had serious allergic reactions after getting Beyfortus (nirsevimab). These reactions can include hives, trouble breathing, or weak muscles. Anaphylaxis has also happened with other monoclonal antibody medications. This can be life-threatening.

If your child has trouble breathing, a severe rash, or swelling in their face, get medical help right away.

Caution use in children with bleeding problems

  • Risk factors: History of bleeding problems | History of low platelets | Taking blood-thinning medication

Tell your child's healthcare professional about if they have a history of bleeding problems, like low platelets. Also make sure to give them a list of your child's current medications. They can check if your child is taking any blood-thinning medications.

If this is the case, your child might still be able to receive Beyfortus (nirsevimab). But their healthcare team will want to keep an eye on them for any bleeding after the injection.

dosage-icon

Beyfortus (nirsevimab) dosage

Typical dosage for Beyfortus (nirsevimab)

Beyfortus (nirsevimab) is injected into the front side of the thigh muscle. It's injected by a trained healthcare professional.

  • Newborns and infants born during or entering their first RSV season

    • Weigh less than 5 kg (11 lbs): The typical dose is 50 mg given as one injection.
    • Weigh 5 kg (11 lbs) or more: The typical dose is 100 mg given as one injection.
  • Children up to 24 months old at risk of severe RSV illness in their second RSV season

    • The typical dose is 200 mg, given as two 100 mg injections during one office visit.

Note: Children who need heart surgery might need an extra dose of Beyfortus (nirsevimab) afterwards.

alternatives-icon

What are alternatives to Beyfortus (nirsevimab)?

There are a number of medications that your doctor can prescribe in place of Beyfortus (nirsevimab). Compare a few possible alternatives below.
Beyfortus (nirsevimab)
Used for:
  • Prevention of respiratory syncytial virus (RSV) in young children of certain ages
    • Newborns and infants born during or entering their first RSV season
    • Children up to 24 months old at risk of severe RSV illness through their second RSV season
Used for:

Prevention of serious respiratory syncytial virus (RSV) infections for:

images-icon

Beyfortus (nirsevimab) images

yellow - Beyfortus 100mg/mL Solution for Injection
This medicine is Yellow Carton.yellow - Beyfortus 100mg/mL Solution for Injection

Get savings updates for Beyfortus (nirsevimab)

Receive price alerts, news, and other messages from GoodRx about Beyfortus (nirsevimab) and other healthcare topics and relevant savings offers.

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

References

Best studies we found

Centers for Disease Control and Prevention. (2023). Respiratory syncytial virus (RSV) preventive antibody: Immunization information statement (IIS).

Centers for Disease Control and Prevention. (2025). Child immunization schedule notes.

Sanofi Pasteur Inc. (2024). Beyfortus- nirsevimab injection [package insert]. DailyMed.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?